Scotiabank and Jefferies Financial Group raised Q4 EPS estimates for Pan American Silver, while simultaneously decreasing the target price and lowering the rating.
2 reports, 1 independent
Updated Sep 3
Gone quiet
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Scotiabank and Jefferies Financial Group raised Q4 EPS estimates for Pan American Silver, while simultaneously decreasing the target price and lowering the rating.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Scotiabank
Canadian bank based in Toronto
-
Pan American Silver
Canadian mining company
Nothing else this week.
-
Jefferies Financial Group
American financial services company
Related events
- Scotiabank raised its price target for NET following the company's Q2 results on August 13, 2025.
- Scotiabank reported strong Q3 earnings and growth on August 28, 2026.
- Multiple financial firms announced rating upgrades, price target increases, and stake acquisitions for various companies on September 7, 2026.
- Jefferies Financial Group reaffirmed a 'buy' rating and issued a $45.00 target price for NewAmsterdam Pharma, Inc.
- Price targets for UDR were adjusted by Cantor Fitzgerald, Scotiabank, and Royal Bank of Canada on May 26, 2026.